Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Succinylated gelatin electrolyte sodium acetate injection for acute normovolemic hemodilution in elective surgery
ChiCTR2500107378Phase 3Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Gelaspan in hypovolemia and None (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Stroke volume (SV) and Hematocrit (Hct). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
Gelaspan
03
Conditions
hypovolemia
Beyond the preview
Go deeper on ChiCTR2500107378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107378.